Cancer Genomics and Proteomics : Impact Factor & More
eISSN: 1790-6245pISSN: 1109-6535
Share this on:
Key Metrics
CiteScore 
6.2
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Genetics
SNIP
0.94
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Genomics and Proteomics
Cancer Genomics and Proteomics Journal Specifications
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
Planning to publish in Cancer Genomics and Proteomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Genomics and Proteomics
Upregulated CircRNAs With Efficacy in Preclinical \u0399n Vivo Models Reveal New Targets for Therapeutic Intervention in Glioma
- 29 Jun 2026
- Cancer Genomics & Proteomics
Genetic Insights into Interleukin-13 Polymorphisms in Colorectal Cancer Risk and Progression
- 29 Jun 2026
- Cancer Genomics & Proteomics
Glucose and Glutamine Define Independent Activation\u2013Braking Metabolic States in Triple Negative Breast Cancer Cells
- 29 Jun 2026
- Cancer Genomics & Proteomics
IL1B-Expressing Exhausted CD4+ T Cells Are Associated With Disease Aggressiveness in Glioblastoma
- 29 Jun 2026
- Cancer Genomics & Proteomics
Reprogramming-driven Proteomic Shifts Mirror Bladder Cancer Progression and Reveal Biomarker Candidates Across Disease Grades
- 29 Jun 2026
- Cancer Genomics & Proteomics
Germline Variation in Notch Pathway and Survival After Androgen Deprivation Therapy in Prostate Cancer: Implicating YAP1 rs1894116 and Focal Adhesion Signaling
- 29 Jun 2026
- Cancer Genomics & Proteomics
Upregulated CircRNAs With Efficacy in Preclinical \u0399n Vivo Models Reveal New Targets for Therapeutic Intervention in Glioma
- 29 Jun 2026
- Cancer Genomics & Proteomics
Genetic Insights into Interleukin-13 Polymorphisms in Colorectal Cancer Risk and Progression
- 29 Jun 2026
- Cancer Genomics & Proteomics
Glucose and Glutamine Define Independent Activation\u2013Braking Metabolic States in Triple Negative Breast Cancer Cells
- 29 Jun 2026
- Cancer Genomics & Proteomics
IL1B-Expressing Exhausted CD4+ T Cells Are Associated With Disease Aggressiveness in Glioblastoma
- 29 Jun 2026
- Cancer Genomics & Proteomics
Reprogramming-driven Proteomic Shifts Mirror Bladder Cancer Progression and Reveal Biomarker Candidates Across Disease Grades
- 29 Jun 2026
- Cancer Genomics & Proteomics
Germline Variation in Notch Pathway and Survival After Androgen Deprivation Therapy in Prostate Cancer: Implicating YAP1 rs1894116 and Focal Adhesion Signaling
- 29 Jun 2026
- Cancer Genomics & Proteomics
FAQs on Cancer Genomics and Proteomics
How long has Cancer Genomics and Proteomics been actively publishing? 
What is the publishing frequency of Cancer Genomics and Proteomics?
How many articles did Cancer Genomics and Proteomics publish last year?
What is the eISSN & pISSN for Cancer Genomics and Proteomics?
What is Citescore for Cancer Genomics and Proteomics?
What is SNIP score for Cancer Genomics and Proteomics?
What is the SJR for Cancer Genomics and Proteomics?
Who is the publisher of Cancer Genomics and Proteomics?
